Physician profile
Mathew Lefkowitz
NPI 1356308340
$336.80
in general payments reported to CMS, 2019-2025
10 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.94 · 2021: $79.62 · 2024: $48.23 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $79.62 | 2021 | |
| Biogen, INC. | $70.04 | 2025 | Vumerity, Skyclarys, Tysabri |
| Avanos Medical | $34.08 | 2025 | Standard Rf Disposables |
| Emd Serono, INC. | $27.83 | 2025 | |
| Depuy Synthes Sales INC. | $27.24 | 2024 | Orthovisc |
| Grifols USA, LLC | $22.36 | 2025 | Gamunex-C |
| Indivior INC. | $20.99 | 2024 | Sublocade |
| Braeburn INC. | $19.58 | 2025 | Brixadi |
| Amgen INC. | $19.12 | 2025 | Uplizna |
| Horizon Therapeutics Plc | $15.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Lefkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.